Patient Rating:

4.6 out of 5

67 Patient Ratings
23 Patient Comments

George M. Rodgers, III, M.D., Ph.D.

Patient Rating:

4.6 out of 5

67 Patient Ratings
23 Patient Comments

Specialties

Languages

  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-2626 Huntsman Cancer Hospital
Hematology Clinic
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Specialties

Bio

George M. Rodgers, M.D., Ph.D. is a Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He also holds an appointment as an adjunct Professor in the Department of Pathology. He is not only the adult hemophilia and thrombosis expert in the state of Utah, but also serves as the adult hemophilia expert for - and receives referrals and consultations from - a six state region. His clinical practice is conducted at the University of Utah's Huntsman Cancer Institute. Dr. Rodgers is also named as the Medical Director for the Coagulation Laboratory at ARUP Laboratories.

For questions regarding Dr. Rodgers' practice, our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist/New Patient Coordinator at http://www.huntsmancancer.org or (801) 587-4630.

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor
Pathology - Adjunct Professor
Academic Divisions Clinical Pathology
Hematology/BMT
Board Certification American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Hematology)
American Board of Pathology (Sub: Hematology)
Federal Licensing Examination
National Board of Medical Examiners

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.6
My confidence in care provider
4.6
Time care provider spent with me
4.6
Care provider spoke using clear language
4.6
Care provider's effort to include me in decisions
4.6
Care provider's concern for questions & worries
4.6
Care provider's explanation of condition/problem
4.6
Wait time at clinic
4.2
Care provider's friendliness and courtesy
4.7

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

September 06, 2014

Dr. Rodgers knew of an appropriate alternative when the conventional treatment made me ill.

August 21, 2014

I think Dr Rogers is world's best at everything he does the way he takes care of me was awesome

August 16, 2014

Great care provided.

August 07, 2014

Dr. Rogers is a consummate professional and incredibly talented. His ability to connect to his patients, kindness and care are unmatched. His clinical skills are ofcourse incredible. He is making a profound difference.

July 25, 2014

Dr. ROger's usually offers me a print out of my lab results. None was offered and I forgot to ask for one.

June 11, 2014

both fellow and attending made sure I understood the plan of care. additionally, they emphasized their availability and to call them with questions. I feel very confident about the plan and that they will intervene and br there to cate for me in futurebe there to care

June 05, 2014

DR, Rodgers and his staff are all great, never had a problem!!

February 11, 2014

I am particularly appreciative of Dr. Rogers, Dr. Nance and Dr. Sana for assuring that all of my hemostasis needs were carefully attended to before and after surgery. I am confident their involvement has improved my recovery from major surgery and amazed that I can actually go through a procedure and not bleed, bruise and ooze forever.

February 05, 2014

I cant help but believe, his care center rates at the top of the scale, world wide!!

January 24, 2014

I thought that we would have had a different experience, our experience was pretty sad. Felt like we had put out the doctor to see us. Maybe it was because the problem wasn't bad enough to be seen there.

November 25, 2013

I don't feel like I am more informed now than I was before. Also, my concerns were largely ignored, about my blood pressure and pain returning.

October 30, 2013

Dr. Rodgers always sits down to talk to you and answers any questions you have.

August 19, 2013

Dr. Rogers is a consummate professional, highly knowledgeable and caring with great deal of emotional intelligence.We are lucky to have him.

June 19, 2013

Since I do not live in the area the provider recommended someone closer or continue coming here to this clinic. Seemed concerned about continuing present treatment.

April 17, 2013

I hated to know I had to take a medicine for the rest of my life, but Dr. Rogers helped me understand 4 reasons why I needed it and how it will prevent future problems in my health and life. He was very kind, understandable and patient with me until he knew I understood. He and his assistant were very kind and helpful. I am so glad I came to see them and now feel more confident about what is happening with my health and medicine.

March 25, 2013

Dr Rogers was excellent. He was especially good at providing clear and detailed information.

February 13, 2013

Very open and friendly in explanations, talked to us in terms/verbage we understood. Answered our questions thoroughly and offered suggestions. Never once acted rushed, and actually asked us if we were ok to wait a few more minutes to get some of the test results. (never have had that treatment at any other office!)

November 14, 2012

I like being in the U of U system. I like being in the U of U system. I am referred from one Dr. to another, and all my information is availale to them. I feel like I am being completely cared for by excellent Docs in their respective fields.

November 11, 2012

Was treated very very very well

October 10, 2012

Patient is a physician; good understanding of information provided

September 15, 2012

Dr. Rodgers seemed in a hurry but is very competent

September 11, 2012

thanks to everyone for your concern

May 01, 2012

Everything still good. Dr, Rogers is wonderful and professional. Feel very comfortable with him and his time with me.

Academic Profile

Research Interests

  • Physiological Regulation of Hemostasis
  • Antithrombotic Therapy
  • Role of Coagulation in Arteriosclerosis
  • Thrombotic Microangiopathies
  • Procoagulant Activities of Vascular Endothelium

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor
Pathology - Adjunct Professor
Academic Divisions Clinical Pathology
Hematology/BMT
Board Certification American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Hematology)
American Board of Pathology (Sub: Hematology)
Federal Licensing Examination
National Board of Medical Examiners

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 213-2076 Huntsman Cancer Institute
Hematology and Hematologic Malignancies
2000 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

George M. Rodgers, M.D., Ph.D. is a Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He also holds an appointment as an adjunct Professor in the Department of Pathology. He is not only the adult hemophilia and thrombosis expert in the state of Utah, but also serves as the adult hemophilia expert for - and receives referrals and consultations from - a six state region. His clinical practice is conducted at the University of Utah's Huntsman Cancer Institute. Dr. Rodgers is also named as the Medical Director for the Coagulation Laboratory at ARUP Laboratories.

The Rodgers' Laboratory has a two-fold research interest statement: 1) basic science on endothelial cell biology and 2) clinical trials on bleeding and clotting disorders. He has published over 200 articles, books and book chapters on hematology and coagulation subjects, over half of which are peer-reviewed journal articles.

Dr. Rodgers received his medical and doctoral degrees from Tulane University, after which he completed a residency in Internal Medicine at Baylor College of Medicine, followed by an Hematology fellowship at the University of California, San Francisco. He is board certified in Internal Medicine, with subspecialty certifications in Internal Medicine and in Hematology. In addition, he holds board certification in Pathology, with a subspecialty certification in Hematology. He currently serves on the Editorial Board for the Journal of the National Comprehensive Cancer Network (JNCCN).

Education

Education History

Type School Degree
Fellowship University of California San Francisco
Hematology/Oncology
Fellow
Residency Baylor College of Medicine
Internal Medicine
Resident
Internship Baylor College of Medicine
Intern
Professional Medical Tulane University
Medicine
M.D.
Doctoral Training Tulane University
Pharmacology
Ph.D.
Undergraduate Louisiana State University
Biochemistry
B.S.

Publications

Selected Provider Publications

Journal Article

  1. Crawford J, Rodgers GM (2014). Treatment strategies for myeloid growth factors and intravenous iron: when, what, and how? J Natl Compr Canc Netw, 12(5 Suppl), 821-4.
  2. Gilreath, Jeffrey A, Stenehjem, David, Rodgers, George M (2014). Diagnosis and Treatment of Cancer-Related Anemia. Am J Hematol, 89, 203-212.
  3. Crawford, Jeffrey and Rodgers, George M (2014). Treatment Strategies in Myeloid Growth Factors and Intravenous Iron: When, What, and How? Journal of the National Comprehensive Cancer Network, 12, 821-824.
  4. Lee M, Keener J, Xiao J, Zheng XL, Rodgers, GM (In press). ADAMTS13 and its variants promote angiogenesis via VEGFR2. Cell Mol Life Sci.
  5. Patel, Shiven B, and Rodgers, George M (In Press). Continuous Infusion of Human Plasma-Derived von Willebrand Factor Concentrate as an Effective Therapy in a Patient with Acquired von Willebrand Disease. Haemophilia.

Review

  1. Gilreath JA, Stenehjem DD, Rodgers GM (2014). Diagnosis and treatment of cancer-related anemia. [Review]. Am J Hematol, 89(2), 203-12.

Book

  1. Bennett, Sterling T, Lehman, Christopher M, and Rodgers, George M (In Press). LABORATORY HEMOSTASIS: A PRACTICAL GUIDE FOR PATHOLOGISTS. New York: Springer.

Edited Book

  1. Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Eds.) (2014). Wintrobe's Clinical Hematology - 13th Edition. (13th ed.). Philadelphia: Lippincott Williams & Wilkins.

Book Chapter

  1. Shami PJ, Rodgers GM (2014). Chapter 19: Endothelium: angiogenesis and the regulation of hemostasis. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 498–507). Philadelphia: Lippincott Williams and Wilkins.
  2. Rodgers GM, Lehman CM (2014). Chapter 45: Diagnostic approach to the bleeding disorders. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1043-1057). Philadelphia: Lippincott Williams & Wilkins.
  3. Rodgers GM (2014). Chapter 46: Thrombocytopenia: pathophysiology and classification. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1058-1060). Philadelphia: Lippincott Williams & Wilkins.
  4. Agarwal AM, Rodgers GM (2014). Chapter 49: Miscellaneous causes of thrombocytopenia. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1097-1105). Philadelphia: Lippincott Williams & Wilkins.
  5. Rodgers GM, Rees MM (2014). Chapter 50: Bleeding disorders caused by vascular abnormalities. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1106-1121). Philadelphia: Lippincott Williams & Wilkins.
  6. Rodgers GM, Means RT (2014). Chapter 51: Thrombocytosis and essential thrombocythemia. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1122-1127). Philadelphia: Lippincott, Williams & Wilkins.
  7. Powell JS, Rodgers GM (2014). Chapter 53: Inherited coagulation disorders. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1143-1185). Philadelphia: Lippincott Williams & Wilkins.
  8. Rodgers GM (2014). Chapter 54: Acquired coagulation disorders. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1186-1217). Philadelphia: Lippincott Williams & Wilkins.
  9. Pendleton RC, Rodgers GM (2014). Chapter 55: Thrombosis and antithrombotic therapy. In Greer JP, Arber DA, Glader BE, List A, Means RT, Paraskevas F, Rodgers GM (Ed.), Wintrobe's Clinical Hematology (13th ed., pp. 1218-1257). Philadelphia: Lippincott Williams & Wilkins.
  10. Lip, Gregory H, Halperin, Jonathan L, Petersen Palle, Rodgers, George M, Pall Denes, and Renfurm, Ronny W (In Press). A phase II, Double-Blind, Randomized, Parallel Group, Dose Finding Study of the Safety and Tolerability of Darexaban Compared with Warfarin in Patients with Non-Valvuler Atrial Fibrillation.
  11. 212 Lee, Manfai, Xiao, Juan, Zheng, X Long, and Rodgers, George M (In Press). ADAMTS13 and Its Variants Promote Angiogenesis Via VEGFR2. In Cell Molec Life Sciences. New York: Springer.
  12. 213 Patel, Shiven B, and Rodgers, George M (In Press). Continuous Infusion of Human Plasma-Derived von Willebrand Factor Concentrate as an Effective Therapy in a Patient with Acquired von Willebrand Disease. In Haemophilia.

Editorial

  1. Gilreath JA, Rodgers GM (2014). Current quandaries in cancer-associated anemia. J Natl Compr Canc Netw, 12(8), 1071-5.

Letter

  1. Rodgers GM (2014). Developmental hemostasis: age-specific differences in the levels of hemostatic proteins: a rebuttal [Letter to the editor]. J Thromb Haemost, 12(2), 285.
  2. Win K, Rodgers GM (2014). New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome [Letter to the editor]. Am J Hematol, 89(10), 1017.
  3. Patel SB, Rodgers GM (2014). Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease [Letter to the editor]. Haemophilia, 20(6), e411-4.
  4. Rodgers, George M (2014). Age-Specific differences in the Levels of Hemostatic Proteins: A Rebuttal [Letter to the editor]. Thromb Haemost, 12, 258.

Abstract

  1. Lee M, Hoyt C, Rodgers GM (In Press). ADAMTS13 expressed in glioblastoma and astrocytoma cells can modulate endothelial cell migration [Abstract]. Blood, 122(21).
  2. Desai DS, Lyon E, Rodgers GM, Jama AJ, Wallentine SL, Smock KJ (In Press). Gene sequencing aids in differentiation of von Willebrand disease type 2B from platelet-type vWD [Abstract]. Clinical Chemistry.

Clinical Trials

Video & News